Evaluation at 5 and 10 Years of Renal Transplant Patients — OXYOP 5 and 10  

Transplant; Complication, Failure Clinical Trial

Official title: Evaluation at 5 and 10 Years of Renal Transplant Patients Who Received a Graft Preserved in a Solution HEMO2life®

Status Not yet recruiting

Clinical Trial Summary

5 and 10 years follow-up of the oxyop study.

Clinical Trial Description

Oxyop (NCT02652520 PHRC) was a safety study evaluating the use of an oxygen carrier HEMO2life® as an additive in organ preservation solution in 60 transplanted kidneys. This was a national multicenter (6 centers) open-labeled safety study on HEMO2life® that included 58 recipients. The first patient was included on March 24th, 2016 and the study was completed on February 23th, 2018 (1 year of recruitment and 1 year of follow-up). Some efficacy secondary end points using a paired analysis was also analyzed (local kidney receiving HEMO2life® versus contralateral kidney transplanted elsewhere in France). Oxyop 5 and 10 years aims to analyse 5 and 10 years results. ;

Related Conditions & MeSH terms

• Transplant; Complication, Failure

• NCT number: NCT05469906
• Study type: Observational
• Source: University Hospital, Brest
• Contact: Yannick Le Meur, MD, PhD
• Phone: 02.98.34.70.74
• Email: yannick.lemeur@chu-brest.fr
• Status: Not yet recruiting
• Start date: July 2022
• Completion date: December 2027